Sign In
Dr. Allison Walsh Kurian, MD
About ProfilePoints™
0 Patient Reviews

Dr. Allison Walsh Kurian, MD

Hematology / Oncology Specialist - Hematologist (Blood)

Highlights

  • Board Certified
  • Accepts Insurance Plans

Biography

Dr. Allison Walsh Kurian, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Palo Alto, CA

She has not yet shared a personalized biography with Doctor.com.

View Phone #Call Now

Are you Dr. Allison Walsh Kurian, MD?

Claim your 100% free Doctor.com profile to:

  • Respond to patient reviews
  • Customize your profile
  • Improve your visibility to our millions of monthly users
Claim your profile

Provider Training

UniversityDegreeFocusGraduated
Harvard Medical School, Boston, MassachusettsMedical Degree1999

InstitutionFocusYear
Internship - Ma Gen Hospital2000
Internship - Massachusetts General Hospital MA 2000
Internship - Massachusetts General Hospital2000
Residency - Massachusetts General Hospital2002
Fellowship - Stanford University School of Medicine CA 2005
Fellowship - Stanford University School of Medicine,Stanford, Ca, United States2005

CertificationCert. BodyYear

Sub-Specialty: Medical Oncology		Internal Medicine2005
Internal medicine
Sub-Specialty: Medical Oncology		Internal Medicine2005

Experience & Accolades

PositionOrganizationTime
Member Career Development Subcommittee, American Society of Clinical Oncology
2008 - 2011
Member American Society of Clinical Oncology
2012 - 2015
Member American Association for Cancer Research
2011 - 2012
Member Track Leader, Cancer Prevention and Epidemiology, Scientific Program Committee
Present
Member American Society of Clinical Oncology
2013 - 2014
MemberOncology Consultant, Breast Cancer Working Group, Cancer Intervention and Surveillance Modeling
Present
Member National Cancer Institute
2014 - 2014
Member Scientific Program Committee, Quality Care Symposium
Present
Director Cancer Education Seminar, Stanford Division of Oncology
2013 - 2014
MemberPanel on Clinical Guidelines Development for Breast Cancer Risk Reduction, National Comprehensive
2013 - 2014
Member Advisory Committee, California HealthCare Foundation
2012 - 2014
Assistant Professor of Medicine Stanford University Medical Center
Present
Member Board of Directors, Santa Clara County, American Cancer Society
2011 - 2014
Member Scientific Program Committee, Cancer Prevention and Epidemiology
Present
MemberPanel on Clinical Guidelines Development for Genetic/ Familial Risk: Breast and Ovarian Cancer
2009 - 2014
Member American Society of Clinical Oncology
2011 - 2014
Associate Director Stanford Clinical Cancer Genetics Program
2007 - 2014
Member Scientific Program Committee, Genetic and Molecular Epidemiology
Present
Associate Member Canary Center at Stanford for Cancer Early Detection
2014 - 2014
Member Program Committee, Professional Development
Present
Member American Society of Clinical Oncology
2008 - 2011

DistinctionInstitutionYear
California Breast Cancer Research Program Translational Research Award 2010
Robert Wood Johnson Foundation Physician Faculty Scholars Award 2008
American Society of Clinical Oncology Young Investigator Award 2005
Cancer Research and Prevention Foundation Fellowship Award 2005
California Breast Cancer Research Program Fellowship Award 2005
American Society of Clinical Oncology Merit Award 2004
California Breast Cancer Research Program Cornelius L. Hopper Research Abstract Award 2007
National Institutes of Health BIRCWH K12 Scholar Award 2006
Top 12 publications funded by the Epidemiology and Genomics Research 2011
Stanford University Cancer Institute Suzanne Pride Bryan Award for Breast Cancer Research 2013
Stanford University Cancer Institute New Clinical Investigator Award 2011
Stanford University Cancer Institute Jan Weimer Faculty Chair for Breast Oncology 2008

Publication Publisher Title Published
Other PublicationJourl of clinical oncology : official jourl of the American Society ofClinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment.
Other PublicationJOURL OF CLINICAL ONCOLOGYOnline Tool to Guide Decisions for BRCA1/2 Mutation Carriers2012
Other PublicationAMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA SymposiumOncoshare: lessons learned from building an integrated multi2012
Other PublicationJOURL OF CLINICAL ONCOLOGYBreast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations2011
Other PublicationJOURL OF CLINICAL ONCOLOGYSurvival Alysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers2010
Other PublicationJOURL OF THE TIOL CANCER INSTITUTESecond Primary Breast Cancer Occurrence According to Hormone Receptor Status2009
Other PublicationJOURL OF CLINICAL ONCOLOGYPerformance of BRCA1/2 mutation prediction models in Asian Americans2008
Other PublicationJOURL OF CLINICAL ONCOLOGYA cost-effectiveness alysis of adjuvant trastuzumab regimens in early HER22007
Other PublicationJAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONCost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonce imaging2006
Other PublicationAMERICAN JOURL OF EPIDEMIOLOGYObesity and Mortality After Breast Cancer by Race2014
Other PublicationJourl of the tiol Comprehensive Cancer NetworkA young woman with bilateral breast cancer2013
Other PublicationJOURL OF ONCOLOGY PRACTICEInformation technology interventions to improve cancer care2013
Other PublicationJOURL OF ADOLESCENT AND YOUNG ADULT ONCOLOGYA Population-Based Observatiol Study of First2013
Other PublicationJOURL OF THE TIOL CANCER INSTITUTEAge-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover2012
Other PublicationPLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
Other PublicationWORLD JOURL OF SURGERYAccuracy of BRCA1/2 Mutation Prediction Models2012
Other PublicationJOURL OF CLINICAL ONCOLOGYIn reply to Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations2012
Other PublicationANLS OF SURGICAL ONCOLOGYA Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer2011
Other PublicationBREAST CANCER RESEARCH AND TREATMENTHigh-resolution melting alysis for rapid screening of BRCA2 founder mutations in Southern Chinese2010
Other PublicationJourl of the tiol Comprehensive Cancer NetworkGenetic/familial high-risk assessment: breast and ovarian.2010
Other PublicationJOURL OF CLINICAL ONCOLOGYIncreasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California2010
Other PublicationJOURL OF CLINICAL ONCOLOGYIn reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al2009
Other PublicationCURRENT ONCOLOGY REPORTSThe Decline in Breast Cancer Incidence: Real or Imagiry?2009
Other PublicationBREAST JOURLMagnetic resonce galactography2008
Other PublicationANLS OF SURGERYCDH1 truncating mutations in the E-cadherin gene2007
Other PublicationBREAST JOURLDuctal pattern enhancement on magnetic resonce imaging of the breast due to ductal lavage2007
Other PublicationCANCERBreast magnetic resonce image screening2004
Other PublicationCancerBreast cancer treatment across health care systems2014
Other PublicationJournal of clinical oncology : official journal of the American SocietClinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment.
Other PublicationBREAST CANCER RESEARCH AND TREATMENTPatterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California2013
Other PublicationJOURNAL OF CLINICAL ONCOLOGYOnline Tool to Guide Decisions for BRCA1/2 Mutation Carriers2012
Other PublicationAMIA ... Annual Symposium proceedings / AMIA Symposium. AMIA SymposiumOncoshare: lessons learned from building an integrated multi2012
Other PublicationJOURNAL OF CLINICAL ONCOLOGYBreast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations2011
Other PublicationJOURNAL OF CLINICAL ONCOLOGYSurvival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers2010
Other PublicationBREAST CANCER RESEARCHLifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups2010
Other PublicationJOURNAL OF THE NATIONAL CANCER INSTITUTESecond Primary Breast Cancer Occurrence According to Hormone Receptor Status2009
Other PublicationJOURNAL OF CLINICAL ONCOLOGYPerformance of BRCA1/2 mutation prediction models in Asian Americans2008
Other PublicationJOURNAL OF CLINICAL ONCOLOGYA cost-effectiveness analysis of adjuvant trastuzumab regimens in early HER22007
Other PublicationJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONCost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging2006
Other PublicationGYNECOLOGIC ONCOLOGYHistologic types of epithelial ovarian cancer: have they different risk factors?2005
Other PublicationAMERICAN JOURNAL OF EPIDEMIOLOGYObesity and Mortality After Breast Cancer by Race2014
Other PublicationRadiologyResponse.2014
Other PublicationCANCER CAUSES & CONTROLThe California Breast Cancer Survivorship Consortium (CBCSC)2013
Other PublicationJournal of the National Comprehensive Cancer NetworkA young woman with bilateral breast cancer2013
Other PublicationFAMILIAL CANCERFeasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers2013
Other PublicationRADIOLOGYThe California Breast Density Information Group
Other PublicationJOURNAL OF ONCOLOGY PRACTICEInformation technology interventions to improve cancer care2013
Other PublicationBREAST CANCER RESEARCH AND TREATMENTA clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk2013
Other PublicationBREAST CANCER RESEARCHImpact of breast cancer subtypes on three-year survival among adolescent and young adult women2013
Other PublicationJOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGYA Population-Based Observational Study of First2013
Other PublicationBREAST CANCER RESEARCH AND TREATMENTNovel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients2012
Other PublicationPLOS ONEIdentification of BRCA12012
Other PublicationFAMILIAL CANCERBreast cancer risk factors differ between Asian and white women with BRCA1/2 mutations2012
Other PublicationCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONA Simulation Model to Predict the Impact of Prophylactic Surgery2012
Other PublicationJOURNAL OF THE NATIONAL CANCER INSTITUTEAge-Specific Incidence of Breast Cancer Subtypes: Understanding the BlackWhite Crossover2012
Other PublicationPLOS ONESingle Cell Profiling of Circulating Tumor Cells2012
Other PublicationCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONPatient, Hospital, and Neighborhood Factors Associated with Treatment of Early2012
Other PublicationWORLD JOURNAL OF SURGERYAccuracy of BRCA1/2 Mutation Prediction Models for Different Ethnicities and Genders: Experience in2012
Other PublicationJOURNAL OF CLINICAL ONCOLOGYIn reply to Breast Cancer Risk for Noncarriers of Family-Specific BRCA1 and BRCA2 Mutations2012
Other PublicationCURRENT BREAST CANCER REPORTSGenetic Polymorphisms as Predictors of Breast Cancer Risk2012
Other PublicationBREAST CANCER RESEARCHOccurrence of breast cancer subtypes in adolescent and young adult women2012
Other PublicationANNALS OF SURGICAL ONCOLOGYA Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer2011
Other PublicationBREAST CANCER RESEARCH AND TREATMENTAsian ethnicity and breast cancer subtypes: a study from the California Cancer Registry2011
Other PublicationCONTEMPORARY OBSTETRICS AND GYNECOLOGYHereditary cancer: counseling women at risk2011
Other PublicationBREAST CANCER RESEARCH AND TREATMENTHigh-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese2010
Other PublicationJournal of the National Comprehensive Cancer NetworkGenetic/familial high-risk assessment: breast and ovarian.2010
Other PublicationJOURNAL OF CLINICAL ONCOLOGYIncreasing Mastectomy Rates for Early-Stage Breast Cancer? Population-Based Trends From California2010
Other PublicationCURRENT OPINION IN OBSTETRICS & GYNECOLOGYBRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications2010
Other PublicationCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONPerformance of Prediction Models for BRCA Mutation Carriage in Three Racial2009
Other PublicationJOURNAL OF CLINICAL ONCOLOGYIn reply to 'Tailoring BRCRAPRO to Asian Americans?' by S. Chen et al2009
Other PublicationCURRENT ONCOLOGY REPORTSThe Decline in Breast Cancer Incidence: Real or Imaginary?2009
Other PublicationCurrent breast cancer reportsStatins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease.2009
Other PublicationFAMILIAL CANCERCancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers2008
Other PublicationBREAST JOURNALMagnetic resonance galactography2008
Other PublicationCANCER GENETICS AND CYTOGENETICSA carrier of both MEN1 and BRCA2 mutations: case report a-lid review of the literature2007
Other PublicationANNALS OF SURGERYCDH1 truncating mutations in the E-cadherin gene2007
Other PublicationBREAST JOURNALDuctal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage2007
Other PublicationAPPLIED PHYSICS LETTERSBiomedical terahertz imaging with a quantum cascade laser2006
Other PublicationHEALTH EXPECTATIONSOpinions of women with high inherited breast cancer risk about prophylactic mastectomy2005
Other PublicationCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTIONDuctal lavage of fluid-yielding and non2005
Other PublicationCANCERBreast magnetic resonance image screening2004

Practice & Hospital Affiliations

Dr. Allison Walsh Kurian, MD has not yet indicated the hospitals that she is affiliated with.

Photos

Provider Profile 0Provider Profile 1

Specialties

Languages Spoken
English
Medical Specialties
  • Hematology / Oncology Specialist - Sub-Specialty: Hematologist (Blood)

Years In Practice: 19 (started in 2006)

Accepts New Patients: Yes

Accepted Insurance

Full Insurance List

Payment Options

Payment Details
We use cookies and limited processing of your personal information for our website and services to function. By using our site, you agree to our use of cookies and our privacy policy.
I Accept